Oncovista Innovative Therapies Inc (OVIT) Financial Statements (2024 and earlier)

Company Profile

Business Address 14785 OMICRON DRIVE
SAN ANTONIO, TX 78245
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments28,06856,03012,51475,63155,93229,871
Cash and cash equivalents28,06856,03012,51475,63155,93229,871
Other undisclosed current assets    43,59543,59550,945
Total current assets:28,06856,03012,514119,22699,52780,816
Noncurrent Assets
TOTAL ASSETS:28,06856,03012,514119,22699,52780,816
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities6,264,9795,930,9715,601,0125,008,7484,680,6623,369,189
Interest and dividends payable20,59712,9958,3294,2671,667 
Employee-related liabilities1,579,2451,460,2921,341,3381,222,3851,103,352 
Accounts payable1,830,8191,747,8191,671,9091,414,0721,364,0721,314,071
Accrued liabilities2,834,3182,709,8652,579,4362,368,0242,211,5712,055,118
Debt190,000110,000200,000200,000101,667 
Derivative instruments and hedges, liabilities    159,067675,26771,751
Estimated litigation liability1,222,817450,000450,000   
Due to related parties1,476,2931,390,2931,240,0001,046,000996,000 
Other liabilities66,00066,00066,00066,00066,000 
Other undisclosed current liabilities(2,855,538)(2,650,585)(2,581,338)(2,268,385)(2,101,019)66,000
Total current liabilities:6,364,5515,296,6794,975,6744,211,4304,418,5773,506,940
Noncurrent Liabilities
Liabilities, other than long-term debt700,000700,000700,000   
Estimated litigation liability700,000700,000700,000   
Total noncurrent liabilities:700,000700,000700,000   
Total liabilities:7,064,5515,996,6795,675,6744,211,4304,418,5773,506,940
Equity
Equity, attributable to parent(7,036,483)(5,940,649)(5,663,160)(4,092,204)(4,319,050)(3,426,124)
Common stock22,01222,01222,01221,62721,62721,627
Additional paid in capital20,217,34120,217,34120,217,34120,217,72620,217,72620,217,726
Accumulated deficit(27,275,836)(26,180,002)(25,902,513)(24,331,557)(24,558,403)(23,665,477)
Total equity:(7,036,483)(5,940,649)(5,663,160)(4,092,204)(4,319,050)(3,426,124)
TOTAL LIABILITIES AND EQUITY:28,06856,03012,514119,22699,52780,816

Income Statement (P&L) (USD)

9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
Operating expenses(1,088,232)(272,824)(1,725,962)(286,754)(287,744)(245,343)
Operating loss:(1,088,232)(272,824)(1,725,962)(286,754)(287,744)(245,343)
Nonoperating income (expense)(7,602)(4,665)155,006513,600(605,182)(62,014)
Interest and debt expense(7,602)  (2,600)(1,667) 
Other undisclosed income from continuing operations before equity method investments, income taxes   4,267   
Income (loss) from continuing operations:(1,103,436)(277,489)(1,566,689)224,246(894,593)(307,357)
Income (loss) before gain (loss) on sale of properties:(1,103,436)(277,489)(1,566,689)224,246(894,593)(307,357)
Net income (loss):(1,103,436)(277,489)(1,566,689)224,246(894,593)(307,357)
Other undisclosed net income (loss) attributable to parent7,602 (4,267)2,6001,667 
Net income (loss) available to common stockholders, diluted:(1,095,834)(277,489)(1,570,956)226,846(892,926)(307,357)

Comprehensive Income (USD)

9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
12/31/2014
Q4
9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
Net income (loss):(1,103,436)(277,489)(1,566,689)224,246(894,593)(307,357)
Comprehensive income (loss), net of tax, attributable to parent:(1,103,436)(277,489)(1,566,689)224,246(894,593)(307,357)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: